Implementing pre-procedural thrombopoietin receptor agonists in cirrhotic patients with severe thrombocytopenia: Indiscriminate, selective or unneeded?

Dig Liver Dis. 2021 Nov;53(11):1394-1395. doi: 10.1016/j.dld.2021.08.004. Epub 2021 Aug 24.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Leukopenia*
  • Liver Cirrhosis / complications
  • Platelet Count
  • Receptors, Thrombopoietin
  • Thrombocytopenia* / drug therapy

Substances

  • Receptors, Thrombopoietin